
DR MICHAEL R JAFF
1.7K posts

DR MICHAEL R JAFF
@docmrjaff
Chief Medical Officer, Peripheral Interventions; VP Med Affairs, Innovation & Technology @ Boston Scientific






Boston Scientific has officially closed the acquisition of @SilkRoadMed. We are excited to enhance our PI portfolio with innovative #TCAR tools and solutions to reduce stroke risk in patients with carotid artery disease during #vascularsurgery. Learn more: bit.ly/3zky0Sy






We’ve entered into a definitive agreement to acquire @silkroadmed, a med tech co. focused on stroke prevention in patients with carotid artery disease through the TCAR procedure. Upon close, we look forward to welcoming the Silk Road team! bit.ly/3KKCqEp


So grateful to the incredible faculty & attendees for an outstanding Vascular Master Class this past weekend. Your dedication to innovation and education is advancing patient care. Be sure to join us Sept 27-28 in Austin, TX for our next program!

Join our expert faculty to discuss strategies, treatment algorithms, & tool selection through case-based didactic presentations & breakout sessions addressing PE & arterial disease management. Register now to be a part of the conversation: cvent.me/yVz1X2 *US-based only











